The insulin resistance of type II diabetes appears to be caused in part by the presence of high levels of lipids in cells such as skeletal muscle where this would not normally be found. The presence of excess lipid stores in skeletal muscle cells interferes with energy metabolism, impairing glucose oxidation and insulin response. Skeletal muscle is one of the primary glucose-consuming tissues, giving it a central role in insulin resistance. The increased risk of diabetes associated with obesity may be caused by increased lipid deposits in skeletal muscle and liver, creating insulin resistance. Leptin is a peptide hormone secreted by adipose tissue that has been associated with many processes. One of the target tissues of leptin is the hypothalamus where it can act to regulate feeding behavior and metabolism. Another leptin target is skeletal muscle. Activation of leptin signaling in skeletal muscle activates the AMP-activated protein kinase (AMP-kinase), known to play a key role in signaling in response to nutrients throughout evolution (See AMPK pathway and Snf1 pathway). AMPK phosphorylates and inactivates the enzyme ACC, acetyl-CoA carboxylase. ACC catalyzes the production of malonyl-CoA from acetyl-CoA. Malonyl-CoA in turn is an inhibitor of the import of fatty acids into mitochondria by carnitine palmitoyl-transferase I for oxidation and energy production (See Mitochondrial carnitine palmitoyl-transferase pathway). In the presence of leptin, AMPK is activated, ACC is inhibited, and malonyl-CoA levels fall, increasing the oxidation of fatty acids and reducing the lipid content of cells. The reduced lipid content in skeletal muscle allows insulin signaling and glucose consumption to return to their normal levels, reducing insulin resistance.
Contributor:
REFERENCES: Greco, A.V. (2002) Insulin Resistance in Morbid Obesity: Reversal With Intramyocellular Fat Depletion. Diabetes 51(1), 144-151 Minokoshi, Y. et al. (2002) Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415(6869), 339-43 Winder ,W.W. (2001) Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle. J. Appl.Physiol. 91(3), 1017-28
蛋白质作为构成人体组织器官的支架和主要物质,在人体生命活动中起着重要作用。蛋白质的相互作用能产生许多效应,如形成特异底物作用通道、生成新的结合位点、失活、作用底物专一性和动力学变化等,细胞的代谢、信号......
2021年9月9日,无锡臻和生物科技有限公司(以下简称“臻和科技”)与美国VyantBio公司签署TissueofOrigin®(以下简称“TOO®”)全球权益和ZL转让协议,全资收购这款唯一获FDA......
2021年7月20日,JournalofCellularPhysiology及JournalofCellularBiochemistry同时撤回了中国学者49篇文章。从2019年开始,Journalo......
磷酸甘油酸突变酶1(PGAM1)通过其代谢活性以及与其他蛋白质(例如α平滑肌肌动蛋白(ACTA2))的相互作用,在癌症代谢和肿瘤进展中起关键作用。变构调节被认为是发现针对PGAM1的高选择性和有效抑制......
2018年12月6日,来自圣迭戈的消息——Illumina公司(纳斯达克股票代码:ILMN)今天宣布推出新型高密度基因分型芯片Infinium™GlobalDiversityArray。这款芯片设计源......
Leptin(LEP)是由脂肪细胞分泌的蛋白质类激素,主要由白色脂肪组织产生。其前体由167个氨基酸残基组成,N末端有21个氨基酸残基信号肽,该前体的信号肽在血液中被切掉而成为146氨基酸,分子量为1......
SDS-PAGE异常电泳现象及分析SDS-PAGEHallofShame.pdf 很不错的东东~~推荐下~......
瘦素(Leptin)是近年新发现的由脂肪细胞分泌的一种由167个氨基酸组成的蛋白质类激素,分子量16000,胃上皮细胞、胎盘组织也有少量表达。瘦素(Leptin)在细胞内产生后,经血液循环到全身各种组......
瘦素(Leptin)是一种由脂肪组织分泌的激素,它在血清中的含量与动物脂肪组织大小成正比。瘦素作用于位于中枢神经系统的受体(LeptinReceptor)从而调控生物的行为以及新陈代谢。当动物体的体脂......
Preparationofdenaturing6%polyacrylamidegelsformicrosatelliteanalysis(alsoforSSAP,high-resolutionIRAP......